{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:14:08Z","timestamp":1757610848992,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91545","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:07:24Z","timestamp":1756919244000},"source":"Crossref","is-referenced-by-count":0,"title":["Clozapine Toxicity Following Aortic Valve Replacement in the Context of Pleural Effusion: A Case Report"],"prefix":"10.7759","author":[{"given":"Adrian","family":"Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana N","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newlyn","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(94)90010-8","article-title":"The side-effects of clozapine: a four year follow-up study","volume":"18","author":"Marinkovic D","year":"1994","unstructured":"Marinkovic D, Timotijevic I, Babinski T, Totic S, Paunovic VR. The side-effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 1994, 18:537-44. 10.1016\/0278-5846(94)90010-8","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1Q642","article-title":"Clozapine-induced peripheral and pleural fluid eosinophilia","volume":"46","author":"Patel JJ","year":"2012","unstructured":"Patel JJ, Lisi PA, Lathara Z, Lipchik RJ. Clozapine-induced peripheral and pleural fluid eosinophilia. Ann Pharmacother. 2012, 46:e4.","journal-title":"Ann Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9147674","article-title":"A case report of a patient with soaring clozapine levels after developing a urinary tract infection","volume":"2024","author":"Kumar Agrawal A","year":"2024","unstructured":"Kumar Agrawal A, Das S, Abednego B Adre L, Raghuma N, Kaushik S, Adhikari A. A case report of a patient with soaring clozapine levels after developing a urinary tract infection. Case Rep Psychiatry. 2024, 2024:9147674. 10.1155\/2024\/9147674","journal-title":"Case Rep Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000621","article-title":"A case report of clozapine-induced pleural effusion in a 28-year-old Chinese male","volume":"28","author":"Wolfe CL","year":"2022","unstructured":"Wolfe CL, Hamilton J, Rogahn M, Brooks S, Ahmed I. A case report of clozapine-induced pleural effusion in a 28-year-old Chinese male. J Psychiatr Pract. 2022, 28:176-9. 10.1097\/PRA.0000000000000621","journal-title":"J Psychiatr Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-977x(03)00061-0","article-title":"Smoking impact on CYP1A2 activity in a group of patients with schizophrenia","volume":"14","author":"Bozikas VP","year":"2004","unstructured":"Bozikas VP, Papakosta M, Niopas I, Karavatos A, Mirtsou-Fidani V. Smoking impact on CYP1A2 activity in a group of patients with schizophrenia. Eur Neuropsychopharmacol. 2004, 14:39-44. 10.1016\/s0924-977x(03)00061-0","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2003.09.010","article-title":"CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients","volume":"20","author":"Doude van Troostwijk LJ","year":"2003","unstructured":"Doude van Troostwijk LJ, Koopmans RP, Vermeulen HD, Guchelaar HJ. CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients. Eur J Pharm Sci. 2003, 20:451-7. 10.1016\/j.ejps.2003.09.010","journal-title":"Eur J Pharm Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200303000-00006","article-title":"The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement","volume":"13","author":"van der Weide J","year":"2003","unstructured":"van der Weide J, Steijns LS, van Weelden MJ. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics. 2003, 13:169-72. 10.1097\/00008571-200303000-00006","journal-title":"Pharmacogenetics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01482.x","article-title":"A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine","volume":"121","author":"Cormac I","year":"2010","unstructured":"Cormac I, Brown A, Creasey S, Ferriter M, Huckstep B. A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine. Acta Psychiatr Scand. 2010, 121:393-7. 10.1111\/j.1600-0447.2009.01482.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00822.x","article-title":"Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance","volume":"46","author":"Schaber G","year":"1998","unstructured":"Schaber G, Stevens I, Gaertner HJ, Dietz K, Breyer-Pfaff U. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance. Br J Clin Pharmacol. 1998, 46:453-9. 10.1046\/j.1365-2125.1998.00822.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001918","article-title":"Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies","volume":"4","author":"Hung SC","year":"2015","unstructured":"Hung SC, Lai YS, Kuo KL, Tarng DC. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc. 2015, 4:10.1161\/JAHA.115.001918","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363286-clozapine-toxicity-following-aortic-valve-replacement-in-the-context-of-pleural-effusion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:07:24Z","timestamp":1756919244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363286-clozapine-toxicity-following-aortic-valve-replacement-in-the-context-of-pleural-effusion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}